Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,717
Total Claims
$677K
Drug Cost
1,102
Beneficiaries
$615
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-91%
Opioid rate vs peers
0.2% vs 2.2% avg
-56%
Cost per patient vs peers
$615 vs $1,411 avg
+18%
Brand preference vs peers
12.5% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
18
Opioid Claims
$642
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,077 claims · $523K
Generic: 7,540 claims · $152K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 52 | $45K |
| Sitagliptin Phosphate | 27 | $39K |
| Rivaroxaban | 38 | $39K |
| Budesonide/Formoterol Fumarate | 51 | $30K |
| Fluticasone/Umeclidin/Vilanter | 26 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 42 | $22K |
| Dulaglutide | 15 | $22K |
| Semaglutide | 12 | $20K |
| Liraglutide | 13 | $18K |
| Fluticasone Propionate | 26 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $12K |
| Tiotropium Br/Olodaterol Hcl | 15 | $11K |
| Milnacipran Hcl | 18 | $10K |
| Fluticasone/Vilanterol | 15 | $9,283 |
| Insulin Nph Hum/Reg Insulin Hm | 17 | $8,973 |
Prescribing Profile
Patient Profile
73
Avg Age
51%
Female
1.34
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data